Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05928611
Other study ID # ENDO 3 - 3 - 5
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date August 2023
Est. completion date September 2024

Study information

Verified date July 2023
Source Cairo University
Contact Wafaa R Elshafaey
Phone 00201020773887
Email wafaa.elshafaey@dentistry.cu.edu.eg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Using intraligmentary dexamethasone to reduce the pain intensity during and after root canal preparation


Description:

Aim :asseing the effect of intraligmentary dexamethasone on anesthetic efficacy of inferior alveolar nerve block and buccal infiltratation in lower first molar with irreversible pulpitis and apical periodontits, dexamethasone has antiinflammatory effect so it will improve the efficacy of anathesia and reduce postoperative by inhibition the production of phosopholipase and reduction of prostaglandins synthesis Methods: diagnose the case clinically and readiographically Patients will divide into 3 groups First group will be given inferior alveolar nerve block 4%articaine Hcl1:100 epinephrine Second group will be given inferior alveolar nerve block 4%articaine with intraligmentary dexamethasone Third group will be given buccal infiltratation 4%articaine with intraligmentary dexamethasone After anathesia ,make access cavity and reduce the occulsa surface and make it out of occulsion . Working length determination will be done by apex locator and confirm it by x ray . Mechanical preparation will be done by FANTA files and apply EDTA on files Irrigate the canal by Naocl 2.5٪ Complete the root canal preparation through single visit. Obturate the canal by single cone technique and bioceramic sealer. During procedures , record pain intensity on HP visual scale Follow up the patient after 6,12,24 and 48 hours Describe Ibuprofen 200mg in case of sever pain Conclusion : it's predictable that the intraligmentary dexamethasone will reduce the pain during and after root canal procedures


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 81
Est. completion date September 2024
Est. primary completion date May 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 45 Years
Eligibility Inclusion Criteria: 1. Age between 20-45 years old. 2. Systemically healthy patient (ASA I or II). 3. Lower first molar with: - Preoperative sharp pain. - Slight widening in the periodontal ligament (PDL). - Vital response of pulp tissue to cold pulp tester (ethyl chloride spray). Exclusion Criteria: 1. Patients allergic to anesthetics, or dexamethasone (other corticosteroids). 2. Pregnant or nursing females. 3. Patients having significant systemic disorder (ASA III or IV). 4. Hemostatic disorders or anti-coagulant therapy during the last month. 5. Consumption of opioid or non-opioid analgesics or corticosteroids during the last 12 h before treatment. 6. Retreatment cases.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Inferior alveolar nerve block with dexamethasone
Using articaine for inferior alveolar block with intraligmentary dexamethasone
Buccal infiltratation with dexamethasone
Using articaine for buccal infiltratation with intraligmentary dexamethasone
Inferior alveolar nerve block
Using articaine for injection

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Outcome

Type Measure Description Time frame Safety issue
Primary Intraoperative pain Efficacy of buccal infiltration anesthesia and inferior alveolar nerve block measured during procedures of root canal treatment using numerical rating scale.It is a line numbered from 0-10 , where pain levels are categorized as follows: 0= no pain, 1-3 = mild pain, 4-6= moderate pain, 7-10= severe pain, "10" being the most intense pain conceivable.And instruct patient to raise his hand if he feels pain to reasse if he needs supplementary anathesia During procedure
Secondary Post-operative pain Patient will record the pain on numerical rating scale (6,12,24 &48h)..It is a line numbered from 0-10 , where pain levels are categorized as follows: 0= no pain, 1-3= mild pain, 4-6= moderate pain, 7-10 = severe pain, "10" being the most intense pain conceivable After procedure until 48hour
Secondary Number of needed analgesic tablets in case of intolerable pain Ibuprofen 200mgm tabs have been described to patient in case of sever pain (above6) After procedure until 48hour
See also
  Status Clinical Trial Phase
Completed NCT06268912 - Cryoanalgesia for Irreversible Pulpitis N/A
Completed NCT06330519 - Impact of Different Techniques on The Efficacy of Anaesthesia in Mandibular Molars With Acute Irreversible Pulpitis Phase 4
Recruiting NCT05336682 - Evaluation of Lesion Sterilization and Tissue Repair Techniques Versus Pulpectomy in Primary Molars With Inflammed Pulp N/A
Recruiting NCT06438523 - A-prf,Nanochitosan Combined With A-prf Compared to Chitosan for Symptomatic Irreversible Pulpitis of Mature Teeth N/A
Recruiting NCT03956199 - Pulpotomy vs.Root Canal Treatment in Managing Irreversible Pulpitis N/A
Completed NCT03174860 - Effect of Preoperative Diclofenac Potassium on Articaine Buccal Infitration Success Phase 2/Phase 3
Completed NCT05853185 - Assessing Success of MTA and Pre-mixed Bioceramic in Mature Teeth With Irreversible Pulpitis With Full Pulpotomy. Phase 4
Not yet recruiting NCT03612323 - Comparison Between Intraligamentary Piroxicam and Articaine Early Phase 1
Not yet recruiting NCT02953912 - Assessment of Postoperative Pain Using Reciproc Versus One Shape Files in Patients With Irreversible Pulpitis N/A
Completed NCT04308863 - Evaluation of Chitosan Scaffold and Mineral Trioxide Aggregate Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis Phase 2
Completed NCT04719247 - Clinical and Radiographic Evaluation of Turmeric, Thymus Vulgaris, Nigella Sativa and Aloe Vera as Pulpotomy Medicaments in Primary Teeth N/A
Completed NCT05582317 - Efficacy of Combination of Biodentine and Simvastatin as a Pulp Capping Materials in Vital Pulpotomy of Primary Molars N/A
Recruiting NCT05402098 - Outcome Following Endodontic Treatment Using Traditional Access Versus Conservative Access N/A
Recruiting NCT05406557 - Partial Versus Miniature Pulpotomy in Teeth With Irreversible Pulpitis N/A
Recruiting NCT05902936 - Evaluation of Nano Bioactive Glass Combined With i-PRF Scaffold in Vital Pulp Treatments N/A
Recruiting NCT03553407 - Analgesic Effect of Low Intensity Laser in Patients With Pulpitis of Mandibular Molars. N/A
Completed NCT05904184 - Comparison of Calcium Silicate-based Sealer and Epoxy Resin-based Sealer Phase 3
Not yet recruiting NCT03916900 - Postoperative Pain and Success Rate in Pulpotomy Versus Root Canal Treatment N/A
Completed NCT06088446 - Effect of Intrapulpal Injections on the Post-endodontic Pain N/A
Enrolling by invitation NCT05964933 - Pulpotomy vs Root Canal Treatment for Teeth With Symptomatic Irreversible Pulpitis N/A